Oxford University leading research on programmable nucleic acid drugs
A consortium led by the University of Oxford researchers has been awarded £8m of funding to unlock the potential of programmable nucleic acid drugs.
Programmable...
Reimagining drug delivery and diagnostics
BioNxt Solutions’ Hugh Rogers explains how the company is driving forward innovation in drug delivery methods and diagnostics technology.
Canadian-headquartered life sciences company, BioNxt Solutions,...
Children on medication for depression has risen by almost 60% in the UK
Prescription of medication for depression in children is up by nearly 60%, according to a new study from the University of Aberdeen.
The same study...
Less than four in 100 men eligible to be sperm donors
International research of over 11,700 men in Denmark and the US finds that less than four in 100 men are accepted as sperm donors.
A...
Vitamin D supplements can reduce the risk of melanoma
Fewer cases of melanoma were found in regular users of vitamin D supplements than in non-users, according to a new study.
People who regularly take...
A new cure for dystonia is under development
A research team in Korea have made significant steps towards finding a cure for dystonia, offering hope to thousands of musicians.
Musicians’ dystonia affects 1-3%...
Perseverant bacteria are weakening antibiotic treatment
Bacterial perseverance is a new phenomenon that could help explain how bacteria are able to adapt to survive antibiotic treatment.
A team of researchers from...
UCL team gain access to the most powerful supercomputer for drug discovery
A UCL-led team of researchers are using the world’s first exascale supercomputer to identify a shortlist of potential new drugs for diseases.
The supercomputer called...
Can ketamine help treat severe alcohol disorder?
A new trial from the University of Exeter will investigate whether ketamine-assisted therapy could help treat alcohol disorder.
The £2.4 million trial will be delivered...
NICE has recommended the anti-cancer drug Enhertu for earlier use
Hundreds more people are now eligible for the breast cancer drug Enhertu as NICE recommends for use in the disease’s early stages
This means NICE...
Over 5,200 people could benefit from new chronic lung disease recommendations
The National Institute of Health and Care Excellence (NICE) has recommended that nintedanib to treat chronic lung disease can be extended to more people....
Over 40,000 doses of Oxford’s Ebola vaccine heading to Uganda
University of Oxford’s Ebola vaccine has been manufactured by SII (Serum Institute of India) in just 60 days and doses shipped to Uganda.
Oxford’s Ebola vaccine...
New mRNA cancer vaccine significantly reduces disease
An mRNA cancer vaccine, developed by Moderna and Merck, demonstrated a statistically significant and clinically meaningful reduction in risk of disease recurrence or death.
The...
WHO warns that bacterial infections are becoming harder to treat
The World Health Organization (WHO) has reported that resistance to antibiotics is on the rise, making the treatment of bacterial infections more difficult.
According to...
Should patients choose their own type 2 diabetes medication?
A new study has suggested that patients should be put in charge of their own type 2 diabetes medication.
The Trimaster large-scale study is the...
Treating cognitive decline after cholestatic liver disease
Patients with cholestatic liver disease may develop neurological symptoms including fatigue and cognitive decline, for which there is currently no cure.
Cholestatic liver diseases such...
Re-examining the safety of fluoroquinolones
A review into the use of fluoroquinolones has found discrepancies in the safety data issued by regulatory bodies.
Fluoroquinolones are commonly prescribed family of antibiotics....
New Alzheimer’s drug Lecanemab shows promising results in trial
A new clinical trial for lecanemab reveals positive results for the future of Alzheimer’s disease treatment.
Study results presented at the 15th Clinical Trials on Alzheimer’s...
Blood thinning medication does not help COVID-19 recovery
Blood thinning medication does not help patients recovering from COVID-19, despite being offered to patients, according to research from the University of Cambridge.
Over 1,000...
High-precision medicine can improve treatment for ovarian cancer
An international team of researchers have found that high-precision medicines can be used in oncology, allowing for better treatment for ovarian cancer.
Mutations of BRCA1...
